Geode Capital Management
IRON icon

Geode Capital Management’s Disc Medicine IRON Stock Holding History

Geode Capital Management’s Portfolio IRON Stock Details IRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$57.8M Buy
789,724
+45,502
+6% +$3.13M ﹤0.01% 1547
2026
Q1 		$47.6M Buy
744,222
+59,264
+9% +$4.11M ﹤0.01% 1517
2025
Q4 		$54.4M Buy
684,958
+56,807
+9% +$4.8M ﹤0.01% 1427
2025
Q3 		$41.5M Buy
628,151
+29,562
+5% +$1.76M ﹤0.01% 1599
2025
Q2 		$31.7M Buy
598,589
+26,605
+5% +$1.25M ﹤0.01% 1694
2025
Q1 		$28.4M Buy
571,984
+99,278
+21% +$5.52M ﹤0.01% 1701
2024
Q4 		$30M Sell
472,706
-2,013
-0.4% -$116K ﹤0.01% 1738
2024
Q3 		$23.3M Buy
474,719
+70,983
+18% +$3.33M ﹤0.01% 1904
2024
Q2 		$18.2M Buy
403,736
+157,962
+64% +$5.37M ﹤0.01% 1978
2024
Q1 		$15.3M Buy
245,774
+16,355
+7% +$1.06M ﹤0.01% 2079
2023
Q4 		$13.3M Buy
229,419
+15,021
+7% +$769K ﹤0.01% 2167
2023
Q3 		$10.1M Buy
214,398
+67,343
+46% +$3.37M ﹤0.01% 2265
2023
Q2 		$6.53M Buy
147,055
+100,017
+213% +$3.55M ﹤0.01% 2548
2023
Q1 		$997K Buy
47,038
+19,878
+73% +$443K ﹤0.01% 3349
2022
Q4 		$540K Buy
27,160
+18,084
+199% +$901K ﹤0.01% 3630
2022
Q3 		$446K Buy
9,076
+39
+0.4% +$1.84K ﹤0.01% 3779
2022
Q2 		$458K Sell
9,037
-5,341
-37% -$236K ﹤0.01% 3823
2022
Q1 		$599K Sell
14,378
-388
-3% -$20.3K ﹤0.01% 3852
2021
Q4 		$1.29M Sell
14,766
-1,025
-6% -$100K ﹤0.01% 3581
2021
Q3 		$1.91M Buy
15,791
+651
+4% +$89K ﹤0.01% 3368
2021
Q2 		$2.94M Buy
15,140
+5,788
+62% +$1.9M ﹤0.01% 3151
2021
Q1 		$3.8M Buy
+9,352
New +$4.17M ﹤0.01% 2915

Other funds holding IRON

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management's IRON Position: Q2 2026 in Review

Geode Capital Management increased its Disc Medicine (IRON) stake by 6.1% in Q2 2026, buying an estimated $3.13M and bringing the position to 789,724 shares worth $57.8M. The position accounts for ﹤0.01% of the portfolio, ranked #1547.

Geode Capital Management first reported a position in IRON in Q1 2021 and has held it in 22 quarters since. 215 funds tracked by Wall St. Rank hold IRON as of Q2 2026.

  • Geode Capital Management held 789,724 shares of Disc Medicine worth $57.8M as of Q2 2026.
  • Geode Capital Management bought 45,502 Disc Medicine shares in Q2 2026, an estimated $3.13M.
  • Disc Medicine made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #1547 holding.
  • Geode Capital Management first reported a position in Disc Medicine in Q1 2021 and has held it in 22 quarters since.
  • 215 funds tracked by Wall St. Rank held Disc Medicine as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.